Security key
092667104
Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA)
CUSIP: 092667104
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Warrants to purchase Class A Common Stock, par value $0.0001 per share
- Shares outstanding
- 85,979,314
- Total 13F shares
- 55,803,558
- Share change
- +3,695,424
- Total reported value
- $233,248,646
- Put/Call ratio
- 16%
- Price per share
- $4.18
- Number of holders
- 126
- Value change
- +$14,870,587
- Number of buys
- 65
- Number of sells
- 52
Report period
Q1 2026
Institutions
126
Top holders
10
SRTA full security history
Previous quarter: Q4 2025
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 092667104
Recent filing periods:
Top shareholders of SRTA - Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
7,110,660
|
$34,202,275 | — | 31 Dec 2025 | |
| Third Point LLC |
13D/G
13F
|
Company |
5.8%
|
5,000,000
|
$25,300,000 | $0 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.1%
from 13D/G
|
4,493,667
mixed-class rows
|
$21,614,302 | — | 31 Dec 2025 | |
| Robert S. Wiesenthal |
3/4/5
|
Director |
6.1%
|
5,275,662
|
$23,371,182 | — | 29 Aug 2025 | |
| Louis R. Verdetto |
3/4/5
|
CEO Keystone Perfusion Service |
1.5%
|
1,266,025
|
$6,456,727 | — | 02 Dec 2025 | |
| Eric L. Affeldt |
3/4/5
|
Director |
0.68%
|
581,214
|
$2,353,916 | — | 01 Aug 2025 | |
| Edward M. Philip |
3/4/5
|
Director |
0.27%
|
234,165
|
$948,368 | — | 01 Aug 2025 | |
| John Borthwick |
3/4/5
|
Director |
0.24%
|
203,977
|
$826,106 | — | 01 Aug 2025 | |
| Kenneth B. Lerer |
3/4/5
|
Director |
0.23%
|
196,859
|
$797,278 | — | 01 Aug 2025 | |
| Susan M. Lyne |
3/4/5
|
Director |
0.22%
|
187,185
|
$758,099 | — | 01 Aug 2025 | |
| Andrew C. Lauck |
3/4/5
|
Director |
0.16%
|
135,642
|
$592,077 | +$21,825 | 05 Dec 2025 | |
| Reginald Love |
3/4/5
|
Director |
0.13%
|
113,897
|
$497,729 | -$95,504 | 20 Nov 2025 | |
| William L. Cook III |
3/4/5
|
Director |
0.06%
|
53,233
|
$271,488 | — | 02 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
3,633,537
|
$17,477,313 | — | 31 Dec 2025 | |
| Northern Right Capital Management, L.P. |
13F
|
Company |
3.3%
|
2,869,014
|
$13,799,957 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
3.3%
|
2,821,468
|
$13,571,261 | — | 31 Dec 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
2.5%
|
2,129,550
|
$10,243,136 | — | 31 Dec 2025 | |
| Pillsbury Lake Capital LLC |
13F
|
Company |
2.3%
|
1,978,252
|
$9,515,392 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
2%
|
1,744,329
|
$8,390,222 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2%
|
1,677,548
|
$8,069,006 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2%
|
1,677,548
|
$8,052,230 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,654,564
|
$7,960,156 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
1,444,950
|
$6,950,492 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
1,331,512
|
$6,404,573 | — | 31 Dec 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
1.5%
|
1,263,987
|
$6,079,777 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
1,117,803
|
$5,376,632 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.89%
|
766,449
|
$3,686,620 | — | 31 Dec 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.89%
|
762,550
|
$3,667,866 | — | 31 Dec 2025 | |
| Creek Drive Management Group LLC |
13F
|
Company |
0.71%
|
610,000
|
$2,934,100 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.7%
|
598,786
|
$2,880,161 | — | 31 Dec 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
592,379
|
$2,849,343 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
485,514
|
$2,335,323 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
473,524
|
$2,277,650 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.42%
|
360,752
|
$1,735,217 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
348,953
|
$1,678,464 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.4%
|
347,162
|
$1,669,849 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.31%
|
269,449
|
$1,296,050 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
254,811
|
$1,225,641 | — | 31 Dec 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.29%
|
250,972
|
$1,207,175 | — | 31 Dec 2025 | |
| Bouvel Investment Partners, LLC |
13F
|
Company |
0.28%
|
243,672
|
$1,172,062 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.23%
|
198,772
|
$956,094 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
194,916
|
$937,546 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.19%
|
163,181
|
$784,901 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
161,070
|
$774,747 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
156,195
|
$751,298 | — | 31 Dec 2025 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.17%
|
147,550
|
$709,716 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
145,992
|
$702,221 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
139,208
|
$669,590 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.15%
|
126,229
|
$607,151 | — | 31 Dec 2025 | |
| Aspen Grove Capital, LLC |
13F
|
Company |
0.15%
|
125,000
|
$601,250 | — | 31 Dec 2025 |
Institutional Holders of Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) as of Q1 2026
As of 31 Mar 2026,
Strata Critical Medical, Inc. - Warrants to purchase Class A Common Stock, par value $0.0001 per share (SRTA) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,803,558 shares.
The largest 10 holders included
ARK Investment Management LLC, Third Point LLC, BlackRock, Inc., Northern Right Capital Management, L.P., VANGUARD CAPITAL MANAGEMENT LLC, AWM Investment Company, Inc., ROYCE & ASSOCIATES LP, Pillsbury Lake Capital LLC, First Eagle Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
126
Q1 2026 holders
126
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.